Gary W. Gullikson

1.0k total citations
43 papers, 832 citations indexed

About

Gary W. Gullikson is a scholar working on Molecular Biology, Physiology and Gastroenterology. According to data from OpenAlex, Gary W. Gullikson has authored 43 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Physiology and 12 papers in Gastroenterology. Recurrent topics in Gary W. Gullikson's work include Gastrointestinal motility and disorders (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Nausea and vomiting management (6 papers). Gary W. Gullikson is often cited by papers focused on Gastrointestinal motility and disorders (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Nausea and vomiting management (6 papers). Gary W. Gullikson collaborates with scholars based in United States and China. Gary W. Gullikson's co-authors include Chafiq Moummi, Daniel L. Flynn, Paul Bass, Timothy S. Gaginella, Daniel P. Becker, Paul R. Nemeth, Ward A. Olsen, Daichang Yang, Roger Nosal and Vilja Lorenzsonn and has published in prestigious journals such as Gastroenterology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Gary W. Gullikson

42 papers receiving 761 citations

Peers

Countries citing papers authored by Gary W. Gullikson

Since Specialization

Citations

This map shows the geographic impact of Gary W. Gullikson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary W. Gullikson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary W. Gullikson more than expected).

Fields of papers citing papers by Gary W. Gullikson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary W. Gullikson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary W. Gullikson. The network helps show where Gary W. Gullikson may publish in the future.

Co-authorship network of co-authors of Gary W. Gullikson

This figure shows the co-authorship network connecting the top 25 collaborators of Gary W. Gullikson. A scholar is included among the top collaborators of Gary W. Gullikson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary W. Gullikson. Gary W. Gullikson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of 3M-003, an imidazoquinoline, on phagocyte candidacidal activity directly and via induction of peripheral blood mononuclear cell cytokines 2010 ·FEMS Immunology & Medical Microbiology ·Elmer Brummer, Mary A. Antonysamy, (unknown), Gary W. Gullikson, David A. Stevens	1
2	Azaadamantane benzamide 5-HT4 agonists: gastrointestinal prokinetic SC-54750 2004 ·Bioorganic & Medicinal Chemistry Letters ·Daniel P. Becker, Daniel L. Flynn, Robert L. Shone, Gary W. Gullikson	12
3	Cyclic AMP-dependent Cl Secretion Is Regulated by Multiple Phosphodiesterase Subtypes in Human Colonic Epithelial Cells 2002 ·The Journal of Membrane Biology ·Scott M. O’Grady, (unknown), Peter J. Maniak, Woubalem Birmachu, (unknown), (unknown), Gary W. Gullikson	41
4	Imiquimod-elicited emesis is mediated by the area postrema, but not by direct neuronal activation 2001 ·Brain Research Bulletin ·N.L. Strominger, Robert J. Brady, Gary W. Gullikson, David O. Carpenter	17
5	Effects of Several Glucocorticosteroids and PDE4 Inhibitors on Increases in Total Lung Eosinophil Peroxidase (EPO) Levels Following Either Systemic or Intratracheal Administration in Sephadexor Ovalbumin-induced Inflammatory Models 2000 ·Inflammation ·(unknown), (unknown), (unknown), (unknown), David Johnson, (unknown), Gary W. Gullikson	2
6	The Demonstration of Bronchodilator Effects of Salbutamol Formulated in Chlorofluorocarbon and Hydrofluoroalkane-134a Metered Dose Inhalation Devices on Leukotriene D ₄ -Induced Pulmonary Responses in the Guinea Pig 1997 ·Journal of Aerosol Medicine ·(unknown), (unknown), (unknown), (unknown), Kiyoshi Takeyama, Gary W. Gullikson	4
7	Polymeric delivery of the active isomer of misoprostol reduces systemic availability and uterotonic activity. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·Gary W. Gullikson, (unknown), Devan V. Mehrotra, (unknown), Robert G. Bianchi, (unknown), (unknown), William E. Perkins	3
8	Serotonin 5-HT3 antagonists fail to affect ethanol self-administration of rats 1994 ·Alcohol ·Patrick M. Beardsley, (unknown), Gary W. Gullikson, Daniel L. Flynn	32
9	SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism. 1993 ·Journal of Pharmacology and Experimental Therapeutics ·Gary W. Gullikson, (unknown), (unknown), (unknown), (unknown), (unknown), Chafiq Moummi, Darren Flynn, (unknown)	51
10	5-HT4 receptor activation induces relaxation and associated cAMP generation in rat esophagus 1992 ·European Journal of Pharmacology ·Chafiq Moummi, Daichang Yang, Gary W. Gullikson	30
11	SC-53116: the first selective agonist at the newly identified serotonin 5-HT4 receptor subtype 1992 ·Journal of Medicinal Chemistry ·Daniel L. Flynn, (unknown), Daniel P. Becker, Roger Nosal, Clara I. Villamil, Gary W. Gullikson, Chafiq Moummi, (unknown)	72
12	Cholecystokinin-mediated ileal electrolyte transport in the guinea pig 1991 ·Gastroenterology ·James F. Kachur, Shuxian Wang, Gary W. Gullikson, Timothy S. Gaginella	2
13	Cholecystokinin-mediated ileal electrolyte transport in the guinea pig 1991 ·Gastroenterology ·James F. Kachur, Shuxian Wang, Gary W. Gullikson, Timothy S. Gaginella	5
14	Potential antisecretory antidiarrheals. 2. .alpha.2-Adrenergic 2-[(aryloxy)alkyl]imidazolines 1990 ·Journal of Medicinal Chemistry ·(unknown), Barnett S. Pitzele, (unknown), Gary W. Gullikson, David M. Albin, Stella S. Yu, Robert G. Bianchi, (unknown), B. Rubin	18
15	Chemistry and structure-activity relationships of C-17 unsaturated 18-cycloalkyl and cycloalkenyl analogs of enisoprost. Identification of a promising new antiulcer prostaglandin 1990 ·Journal of Medicinal Chemistry ·Paul W. Collins, Alan F. Gasiecki, William E. Perkins, Gary W. Gullikson, Robert G. Bianchi, Søren Kramer, John S. Ng, (unknown), (unknown)	10
16	18-Cycloalkyl analogs of enisoprost 1989 ·Journal of Medicinal Chemistry ·Paul W. Collins, Alan F. Gasiecki, William E. Perkins, Gary W. Gullikson, Peter H. Jones, R. F. Bauer	7
17	Potential antisecretory antidiarrheals. 1. .alpha.2-Adrenergic aromatic aminoguanidine hydrazones 1988 ·Journal of Medicinal Chemistry ·Barnett S. Pitzele, (unknown), Gary W. Gullikson, David M. Albin, Robert G. Bianchi, (unknown), Elena Sanguinetti, D. Eric Walters	11
18	Substituted 2-[(2-benzimidazolylsulfinyl)methyl]anilines as potential inhibitors of H+/K+ ATPase 1988 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Richard A. Haack, Stella S. Yu, Gary W. Gullikson, (unknown), (unknown), (unknown), Henry J. Tsai, Robert H. Keith	14
19	Alpha chain unsaturated derivatives of misoprostol 1987 ·Prostaglandins ·Paul W. Collins, Alan F. Gasiecki, Richard M. Weier, Steven W. Kramer, Peter H. Jones, Gary W. Gullikson, Robert G. Bianchi, R. F. Bauer	2
20	Synthesis and gastrointestinal pharmacology of the 4-fluoro analog of enisoprost 1987 ·Journal of Medicinal Chemistry ·(unknown), Steven W. Kramer, Gary W. Gullikson	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact